Efficacy of Isotretinoin in Treating Fungal Infections: A Systematic Review.
Journal of Pioneering Medical Sciences · 2026-07-05 · 15 (6) · 174-185
DOI: 10.47310/jpms2026150623 ↗At a glance
Systematische Übersicht in Journal of Pioneering Medical Sciences, published online on 2026-07-05. Written by Nouf Almagushi and 4 co-authors.
Abstract (original language)
Objective
This systematic review evaluates the effectiveness of oral isotretinoin, either as monotherapy or in combination with antifungal agents, in treating fungal skin infections. Materials and Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) standards were adhered to in drafting the systematic review. An extensive search was performed in the following databases covering the last decade from January 2015 to December 2024: PubMed, Scopus, Web of Science and Google Scholar. The selection of eligible studies adhered to the PICOS criteria (Population, Intervention, Comparator, Outcome and Study design). Due to substantial heterogeneity in study designs, interventions and outcome measures, a quantitative meta-analysis was not feasible and findings were synthesized narratively.
Results
Two hundred forty-nine articles concerning the use of isotretinoin for fungal infections were identified. Titles and abstracts of 152 studies were evaluated, resulting in 54 studies deemed eligible for full-text evaluation. Finally, this review considered 16 studies evaluating isotretinoin regimens ranging from low-dose schedules (10–20 mg/day) to weight-based dosing up to 0.5 mg/kg/day. Four studies were on dermatophytosis, three on seborrhoeic dermatitis and two on pityriasis versicolor and tinea, with isolated reports on chromoblastomycosis and mycosis fungoides. The most consistent evidence of clinical benefit was observed in recurrent dermatophytosis and seborrhoeic dermatitis, especially when isotretinoin was used as an adjunct to the standard therapy. Out of the six studies evaluated using the ROBINS-I tool, three studies exhibited a low RoB and three other studies demonstrated a serious RoB. The RoB 2.0 tool revealed that all the assessed RCTs exhibited high RoB, except for one study that raised some concerns.
Conclusion
Isotretinoin has potential in the adjuvant treatment of fungal infections especially recurrent dermatophytosis but is more of a supportive than a standalone therapy. Clinical relevance: Isotretinoin may be a promising adjunctive therapy, especially in recurrent dermatophytosis and should be further investigated as a way to improve treatment outcomes and reduce disease recurrence.
Cite
APA
Almagushi, N., Alzayyat, R., Alajlani, A., Alheggi, A., & Aleissa, M. (2026). Efficacy of Isotretinoin in Treating Fungal Infections: A Systematic Review. Journal of Pioneering Medical Sciences, 15(6), 174-185. https://doi.org/10.47310/jpms2026150623
Vancouver
Almagushi N, Alzayyat R, Alajlani A, Alheggi A, Aleissa M. Efficacy of Isotretinoin in Treating Fungal Infections: A Systematic Review. Journal of Pioneering Medical Sciences. 2026;15(6):174-185. doi:10.47310/jpms2026150623
BibTeX
@article{Almagushi2026,
author = {Almagushi, Nouf and Alzayyat, Remah and Alajlani, Ajlan and Alheggi, Ashjan and Aleissa, Majed},
title = {Efficacy of Isotretinoin in Treating Fungal Infections: A Systematic Review},
journal = {Journal of Pioneering Medical Sciences},
year = {2026},
volume = {15},
number = {6},
pages = {174--185},
doi = {10.47310/jpms2026150623}
}
EUVIMED